These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14707735)

  • 1. The enzyme levels in blood are not affected by oral administration of a pancreatic enzyme preparation (Creon 10,000) in pancreas-insufficient pigs.
    Gewert K; Holowachuk SA; Rippe C; Gregory PC; Erlanson-Albertsson C; Olivecrona G; Kruszewska D; Piedra JV; Weström B; Pierzynowski SG
    Pancreas; 2004 Jan; 28(1):80-8. PubMed ID: 14707735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring changes in plasma levels of pancreatic and intestinal enzymes in a model of pancreatic exocrine insufficiency--induced by pancreatic duct-ligation--in young pigs.
    Lozinska L; Prykhodko O; Sureda EA; Szwiec K; Podgurniak P; Pierzynowski S; Weström B
    Adv Med Sci; 2015 Mar; 60(1):112-7. PubMed ID: 25658045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total pancreatic insufficiency in pigs: a model to study intestinal enzymes and plasma levels of digestive hormones after pancreatic supplementation by a whole pancreas preparation.
    Abello J; Pascaud X; Simoes-Nunes C; Cuber JC; Junien JL; Rozé C
    Pancreas; 1989; 4(5):556-64. PubMed ID: 2478998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery.
    Gubergrits N; Malecka-Panas E; Lehman GA; Vasileva G; Shen Y; Sander-Struckmeier S; Caras S; Whitcomb DC
    Aliment Pharmacol Ther; 2011 May; 33(10):1152-61. PubMed ID: 21418260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
    Kuhn RJ; Gelrud A; Munck A; Caras S
    Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis.
    Trapnell BC; Maguiness K; Graff GR; Boyd D; Beckmann K; Caras S
    J Cyst Fibros; 2009 Dec; 8(6):370-7. PubMed ID: 19815466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous pancreatic-like enzymes are recovered in the gut and improve growth of exocrine pancreatic insufficient pigs.
    Pierzynowski S; Szwiec K; Valverde Piedra JL; Gruijc D; Szymanczyk S; Swieboda P; Prykhodko O; Fedkiv O; Kruszewska D; Filip R; Botermans J; Svendsen J; Ushakova G; Kovalenko T; Osadchenko I; Goncharova K; Skibo G; Weström B
    J Anim Sci; 2012 Dec; 90 Suppl 4():324-6. PubMed ID: 23365368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.
    Whitcomb DC; Lehman GA; Vasileva G; Malecka-Panas E; Gubergrits N; Shen Y; Sander-Struckmeier S; Caras S
    Am J Gastroenterol; 2010 Oct; 105(10):2276-86. PubMed ID: 20502447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An elemental diet fed, enteral or parenteral, does not support growth in young pigs with exocrine pancreatic insufficiency.
    Rengman S; Fedkiv O; Botermans J; Svendsen J; Weström B; Pierzynowski S
    Clin Nutr; 2009 Jun; 28(3):325-30. PubMed ID: 19297056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability.
    Aloulou A; Puccinelli D; Sarles J; Laugier R; Leblond Y; Carrière F
    Aliment Pharmacol Ther; 2008 Feb; 27(3):283-92. PubMed ID: 17973644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creon 10,000 Minimicrospheres vs. Creon 8,000 microspheres--an open randomised crossover preference study.
    Patchell CJ; Desai M; Weller PH; Macdonald A; Smyth RL; Bush A; Gilbody JS; Duff SA
    J Cyst Fibros; 2002 Dec; 1(4):287-91. PubMed ID: 15463829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience with the use of 13C-breath test for the evaluation of the efficacy of enzyme substitution therapy with microencapsulated pancreatinin in patients with severe primary pancreatic insufficiency].
    Rapoport SI; Maev IV; Kucheriavyĭ IuA; Shubina NA; Semenova NV; Stukova NIu; Archakov AI
    Klin Med (Mosk); 2009; 87(1):53-7. PubMed ID: 19256262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiments to optimize enzyme substitution therapy in pancreatic duct-ligated pigs.
    Kammlott E; Karthoff J; Stemme K; Gregory P; Kamphues J
    J Anim Physiol Anim Nutr (Berl); 2005; 89(3-6):105-8. PubMed ID: 15787979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of CREON® pancrelipase pellets via gastrostomy tube is feasible with no loss of gastric resistance or lipase activity: an in vitro study.
    Shlieout G; Koerner A; Maffert M; Forssmann K; Caras S
    Clin Drug Investig; 2011; 31(7):e1-7. PubMed ID: 21627335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growing pancreatic duct ligated pig as a model for exocrine pancreatic insufficiency in children: investigations to achieve sufficient vitamin A and vitamin E supply.
    Mösseler A; Schwarzmaier T; Grunemann J; Gregory PC; Höltershinken M; Kamphues J
    J Anim Sci; 2012 Dec; 90 Suppl 4():321-3. PubMed ID: 23365367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis.
    Santini B; Antonelli M; Battistini A; Bertasi S; Collura M; Esposito I; Di Febbraro L; Ferrari R; Ferrero L; Iapichino L; Lucidi V; Manca A; Pisconti CL; Pisi G; Raia V; Romano L; Rosati P; Grazioli I; Melzi G
    Dig Liver Dis; 2000; 32(5):406-11. PubMed ID: 11030186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of an omega-3 substrate challenge absorption test as an indicator of global fat lipolysis.
    Freedman SD; Zaworski K; Pierzynowska K; Pierzynowski S; Gallotto R; Sathe M; Borowitz DS
    PLoS One; 2023; 18(5):e0284651. PubMed ID: 37155649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis.
    Safdi M; Bekal PK; Martin S; Saeed ZA; Burton F; Toskes PP
    Pancreas; 2006 Aug; 33(2):156-62. PubMed ID: 16868481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of the 3H-triolein assay for pancreatic lipase in blood plasma.
    Gewert K; Gregory PC; Olivecrona G; Erlanson-Albertsson C; Pierzynowski SG
    Clin Chem Lab Med; 2005; 43(11):1211-4. PubMed ID: 16232087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma immunoreactive cationic trypsin(ogen) pattern in reserpinized rat model of cystic fibrosis. Resemblance to humans.
    Weizman Z
    Dig Dis Sci; 1996 May; 41(5):853-8. PubMed ID: 8625754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.